April 12, 2018 / 6:29 AM / 5 months ago

BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cyproheptadine Hydrochloride Tablets

April 12 (Reuters) - Strides Shasun Ltd:

* GETS USFDA APPROVAL FOR CYPROHEPTADINE HYDROCHLORIDE TABLETS

* PRODUCT WILL BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE

* PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN U.S MARKET

* SAYS DRUG IS INDICATED TO RELIEVE ALLERGY SYMPTOMS Source text - bit.ly/2GUG4J2 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below